• Ruxolitinib (INCB018424): Precision JAK1/2 Inhibition for Tr

  2026-04-28

  Explore how Ruxolitinib (INCB018424) transforms myeloproliferative disorder research through highly selective JAK-STAT pathway inhibition. This deep dive reveals mechanistic insights and advanced assay considerations not covered elsewhere, anchoring APExBIO's product at the center of translational immunology innovation.

• (+)-Bicuculline: Technical Guidance for Neuroscience Researc

  2026-04-27

  (+)-Bicuculline is a classical GABAA receptor antagonist used to dissect inhibitory neurotransmission and synaptic NMDA receptor signaling pathways in neuroscience research. It is not suitable for clinical or diagnostic applications, and optimal results depend on rigorous adherence to solubility, storage, and workflow best practices.

• Erastin: Precision Ferroptosis Inducer for Cancer Research

  2026-04-27

  Erastin empowers researchers to selectively induce ferroptosis and probe redox vulnerabilities in RAS/BRAF-mutant tumor cells. This guide decodes practical workflows, optimization tactics, and troubleshooting strategies for leveraging Erastin in advanced cancer biology research.

• VLCFA-Driven Peroxisome Dynamics in Gut Regeneration via PPA

  2026-04-26

  Guo et al. (2024) uncover how very long-chain fatty acids (VLCFAs) act as niche signals to regulate peroxisome proliferation in intestinal stem cells (ISCs) during gut regeneration. Their work reveals a precise feedback loop between PPARs and SOX21 that orchestrates peroxisome dynamics, offering new insights into tissue repair mechanisms.

• WNT5a/GSK3/β-catenin Axis Regulates Muscle FAP Adipogenesis

  2026-04-25

  This study reveals that the WNT5a/GSK3/β-catenin signaling axis critically restrains adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors (FAPs), impacting muscle regeneration and fatty degeneration. Through integrated pharmacological, cytometric, and transcriptomic approaches, the research defines canonical Wnt signaling as a modulator of FAP fate and suggests potential intervention points for muscle disease and stem cell research.

• Rack1-Mediated Ferroptosis Alters Hindgut Development in ARM

  2026-04-24

  This study reveals that Rack1 regulates ferroptosis via the P38-MAPK/Nqo1/Gpx4 axis during rat hindgut development, contributing to anorectal malformations (ARM). Spatial transcriptomics underscores ferroptosis as a critical cell death pathway in ARM pathogenesis, opening new avenues for developmental biology and targeted research.

• Ultra Fast LC–MS/MS for Cefazedone and Etimicin Pharmacokine

  2026-04-24

  This study presents a validated ultra fast LC–MS/MS method for simultaneous quantification of cefazedone and etimicin in beagle dog plasma. The work enables robust pharmacokinetic profiling of combination antibiotic therapies, supporting more precise evaluation of drug interactions and dosing regimens.

• H 89 2HCl: Strategic PKA Inhibition for Translational Resear

  2026-04-23

  This thought-leadership article explores how H 89 2HCl, a potent and selective protein kinase A inhibitor, empowers translational researchers to dissect cAMP/PKA signaling with unprecedented precision. By integrating mechanistic insights from recent neuroinflammation research and benchmarking experimental strategies, we highlight the product’s unique value for advancing pain biology, neurodegeneration, and beyond. The discussion foregrounds protocol guidance, competitive context, and a forward-looking perspective on pathway-selective modulation.

• Low-Dose Decitabine Restores T-cell Balance in Immune Thromb

  2026-04-23

  This study demonstrates that low-dose Decitabine (5-Aza-2'-deoxycytidine) rebalances T-cell subsets and restores immune tolerance in immune thrombocytopenia (ITP) by augmenting regulatory T cell function and suppressing pro-inflammatory T-cell populations. These findings suggest a mechanistic rationale for Decitabine's sustained clinical benefits in refractory ITP and inform new immunomodulatory strategies for hematopoietic malignancy research.

• MLN2238: Advanced Insights into Proteasome β5 Inhibition and

  2026-04-22

  Explore how MLN2238, a potent proteasome β5 subunit inhibitor, uniquely shapes cellular proteostasis and CREB axis signaling. This article unveils novel mechanistic insights and assay guidance, providing a deeper lens beyond existing content.

• Docetaxel in Cancer Chemotherapy Research: Optimizing Assays

  2026-04-22

  Docetaxel (Taxotere) is pivotal in cancer chemotherapy research, offering potent microtubule stabilization and apoptosis induction across diverse tumor models. This article details robust experimental protocols, troubleshooting approaches, and the latest workflow innovations, enabling researchers to harness Docetaxel’s full potential in both in vitro and in vivo contexts.

• GZMK+ CD8+ T Cells Drive Recurrence in Airway Inflammatory D

  2026-04-21

  This study uncovers a pathogenic subset of GZMK-expressing CD8+ T cells that persist in nasal polyp tissue and promote recurrence in chronic airway inflammatory diseases. By combining TCR repertoire analysis and functional assays, the authors identify GZMK as a key effector and potential therapeutic target for recurrent airway inflammation.

• VDR Activation Inhibits Ferroptosis in Cisplatin-Induced AKI

  2026-04-21

  This study establishes that vitamin D receptor (VDR) activation attenuates cisplatin-induced acute kidney injury (AKI) by inhibiting ferroptosis, a regulated, iron-dependent cell death pathway. The research demonstrates that VDR directly upregulates GPX4, mitigating lipid peroxidation and protecting renal tissue, and offers new mechanistic insight with potential translational relevance.

• Transmission Dynamics of Carbapenemase Genes in CREC, Guangd

  2026-04-20

  This study offers a detailed molecular and epidemiological characterization of carbapenemase-encoding gene dissemination in carbapenem-resistant Enterobacter cloacae (CREC) across eight teaching hospitals in Guangdong during the COVID-19 pandemic. Its findings highlight the dominant role of plasmid-borne blaNDM−1 in multidrug resistance and reveal high rates of horizontal gene transfer, with direct implications for surveillance and infection control strategies.

• Safe DNA Gel Stain: High-Sensitivity, Less Mutagenic DNA/RNA

  2026-04-20

  Safe DNA Gel Stain offers a high-sensitivity, safer alternative for DNA and RNA gel staining in molecular biology. This product improves nucleic acid visualization while reducing mutagenic risk and DNA damage during gel imaging, supporting higher cloning efficiency and workflow safety.

450 records 20/30 page Previous Next First page 上5页 1617181920 下5页 Last page